Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Diabetes and Cardiovascular Disease
1999 Standout
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Congenital Heart Disease in the General Population
2007 Standout
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke
2015
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Birth Prevalence of Congenital Heart Disease Worldwide
2011 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Sleep-disordered breathing and stroke
2003
Spectrum of congenital heart disease in Malta. An excess of lesions causing right ventricular outflow tract obstruction in a population-base study
1998
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
2003 Standout
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
2012
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
2007 Standout
Early clinical screening of neonates for congenital heart defects: the cases we miss
1999
Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: Results of the STACK-on to ENOXaparin (STACKENOX) study
2009
Incidence and risk factors for ventricular septal defect in “low risk” neonates
1999
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Prevalence of Congenital Heart Defects in Metropolitan Atlanta, 1998-2005
2008
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Prevalence of congenital heart disease
2004 Standout
Fish Intake, Contaminants, and Human Health
2006 Standout
Genetic Basis for Congenital Heart Defects: Current Knowledge
2007
Psychological Stress and Cardiovascular Disease
2008 Standout
The incidence of congenital heart disease
2002 Standout
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention
2010
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women
2009 Standout
The changing epidemiology of congenital heart disease
2010
GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5
2003 StandoutNature
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
2008 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Validation of the Framingham Coronary Heart Disease Prediction Scores
2001 Standout
Inbreeding and congenital heart diseases in a North Indian population
1994
Fibrinogen Is a Predictor of Mortality in Coronary Heart Disease Patients
1996
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
2008
Definition of Metabolic Syndrome
2004 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
2005 Standout
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
1999 Standout
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
2007 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
2008
General Cardiovascular Risk Profile for Use in Primary Care
2008 Standout
Racial and Temporal Variations in the Prevalence of Heart Defects
2001
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
2012 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Preventives Versus Treatments *
2015 StandoutNobel
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Works of Nathan Roguin being referenced
Consanguinity and Congenital Heart Disease in the Rural Arab Population in Northern Israel
1986
High prevalence of muscular ventricular septal defect in preterm neonates
1996
Clinical and echocardiographic evaluation of neonates with heart murmurs
1997
Percutaneous Coronary Intervention in Patients Receiving Enoxaparin or Unfractionated Heparin After Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction in the ExTRACT-TIMI 25 Trial
2007
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) study
1995
High prevalence of muscular ventricular septal defect in neonates
1995
Spontaneous closure of muscular ventricular septal defect identified by echocardiography in neonates
1998
Pericarditis and pericardial effusion in acute ST-elevation myocardial infarction in the thrombolytic era.
2002